Literature DB >> 15027898

Central and peripheral autoantigen presentation in immune tolerance.

Alberto Pugliese1.   

Abstract

Recent studies in both humans and experimental rodent models provide new insight into key mechanisms regulating tolerance to self-molecules. These recent advances are bringing about a paradigm shift in our views about tolerance to self-molecules with tissue-restricted expression. There is, indeed, mounting evidence that selected antigen-presenting cells (APCs) have the ability to synthesize and express self-molecules, and that such expression is critical for self-tolerance. Insulin is a key hormone produced exclusively by pancreatic beta-cells and a critical autoantigen in type 1 diabetes. It provides an excellent example of a molecule with tissue-restricted expression that is expressed ectopically by APCs. The fact that APCs expressing insulin have been demonstrated in both thymus and peripheral lymphoid tissues suggests that they may play a role in insulin presentation in both the central and peripheral immune system. Experimental mice, in which insulin expression was altered, provide functional data that help to dissect the role of insulin presentation by APCs of the immune system. This review addresses recent literature and emerging concepts about the expression of self-molecules in the thymus and peripheral lymphoid tissues and its relation to self-tolerance.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15027898      PMCID: PMC1782408          DOI: 10.1111/j.0019-2805.2003.01804.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  84 in total

1.  Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library.

Authors:  F S Wong; J Karttunen; C Dumont; L Wen; I Visintin; I M Pilip; N Shastri; E G Pamer; C A Janeway
Journal:  Nat Med       Date:  1999-09       Impact factor: 53.440

2.  Autoimmune regulator is expressed in the cells regulating immune tolerance in thymus medulla.

Authors:  M Heino; P Peterson; J Kudoh; K Nagamine; A Lagerstedt; V Ovod; A Ranki; I Rantala; M Nieminen; J Tuukkanen; H S Scott; S E Antonarakis; N Shimizu; K Krohn
Journal:  Biochem Biophys Res Commun       Date:  1999-04-21       Impact factor: 3.575

3.  Transcription of a broad range of self-antigens in human thymus suggests a role for central mechanisms in tolerance toward peripheral antigens.

Authors:  M Sospedra; X Ferrer-Francesch; O Domínguez; M Juan; M Foz-Sala; R Pujol-Borrell
Journal:  J Immunol       Date:  1998-12-01       Impact factor: 5.422

Review 4.  Peripheral-antigen-expressing cells in thymic medulla: factors in self-tolerance and autoimmunity.

Authors:  D Hanahan
Journal:  Curr Opin Immunol       Date:  1998-12       Impact factor: 7.486

Review 5.  Aberrant expression of tissue-specific proteins in the thymus: a hypothesis for the development of central tolerance.

Authors:  O Werdelin; U Cordes; T Jensen
Journal:  Scand J Immunol       Date:  1998-02       Impact factor: 3.487

6.  Pancreatic hormone expression in the murine thymus: localization in dendritic cells and macrophages.

Authors:  M Throsby; F Homo-Delarche; D Chevenne; R Goya; M Dardenne; J M Pleau
Journal:  Endocrinology       Date:  1998-05       Impact factor: 4.736

7.  The role of MHC class II molecules in susceptibility to type I diabetes: identification of peptide epitopes and characterization of the T cell repertoire.

Authors:  C C Chao; H K Sytwu; E L Chen; J Toma; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

8.  Natural and induced apoptosis during lymphocyte development in the axolotl.

Authors:  P Ducoroy; M Lesourd; M R Padros; A Tournefier
Journal:  Dev Comp Immunol       Date:  1999-04       Impact factor: 3.636

9.  Cloned T cells from a recent onset IDDM patient reactive with insulin B-chain.

Authors:  N C Schloot; S Willemen; G Duinkerken; R R de Vries; B O Roep
Journal:  J Autoimmun       Date:  1998-04       Impact factor: 7.094

10.  Intrathymic expression of genes involved in organ specific autoimmune disease.

Authors:  V L Heath; N C Moore; S M Parnell; D W Mason
Journal:  J Autoimmun       Date:  1998-08       Impact factor: 7.094

View more
  13 in total

1.  Environmental factors and primary prevention in type 1 diabetes.

Authors:  Jorma Ilonen; Outi Vaarala; Hans K Akerblom; Mikael Knip
Journal:  Pediatr Endocrinol Diabetes Metab       Date:  2009

2.  Novel gene associations in type 1 diabetes.

Authors:  Jorma Ilonen; Robert Hermann
Journal:  Curr Diab Rep       Date:  2010-10       Impact factor: 4.810

3.  Priming and effector dependence on insulin B:9-23 peptide in NOD islet autoimmunity.

Authors:  Maki Nakayama; Joshua N Beilke; Jean M Jasinski; Masakazu Kobayashi; Dongmei Miao; Marcella Li; Marilyne G Coulombe; Edwin Liu; John F Elliott; Ronald G Gill; George S Eisenbarth
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

Review 4.  Influence of type 1 diabetes genes on disease progression: similarities and differences between countries.

Authors:  Johanna Lempainen; Jorma Ilonen
Journal:  Curr Diab Rep       Date:  2012-10       Impact factor: 4.810

Review 5.  Potential functional role of plasmacytoid dendritic cells in cancer immunity.

Authors:  Ryungsa Kim; Manabu Emi; Kazuaki Tanabe; Koji Arihiro
Journal:  Immunology       Date:  2007-03-20       Impact factor: 7.397

Review 6.  Mechanisms of autoimmunity in the non-obese diabetic mouse: effector/regulatory cell equilibrium during peak inflammation.

Authors:  Nadir Askenasy
Journal:  Immunology       Date:  2016-02-08       Impact factor: 7.397

7.  Alternative splicing of G6PC2, the gene coding for the islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP), results in differential expression in human thymus and spleen compared with pancreas.

Authors:  R S Dogra; P Vaidyanathan; K R Prabakar; K E Marshall; J C Hutton; A Pugliese
Journal:  Diabetologia       Date:  2006-03-07       Impact factor: 10.122

8.  Effect of the PTPN22 and INS risk genotypes on the progression to clinical type 1 diabetes after the initiation of β-cell autoimmunity.

Authors:  Johanna Lempainen; Robert Hermann; Riitta Veijola; Olli Simell; Mikael Knip; Jorma Ilonen
Journal:  Diabetes       Date:  2012-02-22       Impact factor: 9.461

9.  Autoantigen presentation by splenic dendritic cells is required for RBC-specific autoimmunity.

Authors:  Amanda L Richards; Annie Qiu; Flavia Dei Zotti; Kathryn Sheldon; Chomkan Usaneerungrueng; David R Gruber; Krystalyn E Hudson
Journal:  Transfusion       Date:  2020-11-17       Impact factor: 3.337

10.  Activation of insulin-reactive CD8 T-cells for development of autoimmune diabetes.

Authors:  F Susan Wong; Lai Khai Siew; Gwen Scott; Ian J Thomas; Stephen Chapman; Christophe Viret; Li Wen
Journal:  Diabetes       Date:  2009-02-10       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.